Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 1/2014

01-01-2014

Modeling thrombin generation: plasma composition based approach

Authors: Kathleen E. Brummel-Ziedins, Stephen J. Everse, Kenneth G. Mann, Thomas Orfeo

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2014

Login to get access

Abstract

Thrombin has multiple functions in blood coagulation and its regulation is central to maintaining the balance between hemorrhage and thrombosis. Empirical and computational methods that capture thrombin generation can provide advancements to current clinical screening of the hemostatic balance at the level of the individual. In any individual, procoagulant and anticoagulant factor levels together act to generate a unique coagulation phenotype (net balance) that is reflective of the sum of its developmental, environmental, genetic, nutritional and pharmacological influences. Defining such thrombin phenotypes may provide a means to track disease progression pre-crisis. In this review we briefly describe thrombin function, methods for assessing thrombin dynamics as a phenotypic marker, computationally derived thrombin phenotypes versus determined clinical phenotypes, the boundaries of normal range thrombin generation using plasma composition based approaches and the feasibility of these approaches for predicting risk.
Literature
1.
go back to reference Raskob GE, Silverstein R, Bratzler DW, Heit JA, White RH (2010) Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med 38:S502–S509PubMed Raskob GE, Silverstein R, Bratzler DW, Heit JA, White RH (2010) Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med 38:S502–S509PubMed
2.
go back to reference Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J (2011) Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation 123:e18–e209PubMed Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J (2011) Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation 123:e18–e209PubMed
3.
go back to reference Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ (2011) Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123:933–944PubMed Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ (2011) Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123:933–944PubMed
4.
go back to reference Mann KG, Orfeo T, Butenas S, Undas A, Brummel-Ziedins K (2009) Blood coagulation dynamics in haemostasis. Hamostaseologie 29:7–16PubMedCentralPubMed Mann KG, Orfeo T, Butenas S, Undas A, Brummel-Ziedins K (2009) Blood coagulation dynamics in haemostasis. Hamostaseologie 29:7–16PubMedCentralPubMed
5.
go back to reference Anderson JA, Weitz JI (2010) Hypercoagulable states. Clin Chest Med 31:659–673PubMed Anderson JA, Weitz JI (2010) Hypercoagulable states. Clin Chest Med 31:659–673PubMed
6.
go back to reference Heit JA (2007) Thrombophilia: common questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program 1:127–135 Heit JA (2007) Thrombophilia: common questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program 1:127–135
7.
go back to reference Fraser JS, Gross JD, Krogan NJ (2013) From systems to structure: bridging networks and mechanism. Mol Cell 49:222–231PubMed Fraser JS, Gross JD, Krogan NJ (2013) From systems to structure: bridging networks and mechanism. Mol Cell 49:222–231PubMed
8.
go back to reference Chakrabarti A, Miskovic L, Soh KC, Hatzimanikatis V (2013) Towards kinetic modeling of genome-scale metabolic networks without sacrificing stoichiometric, thermodynamic and physiological constraints. Biotechnol J 8:1043–1057PubMed Chakrabarti A, Miskovic L, Soh KC, Hatzimanikatis V (2013) Towards kinetic modeling of genome-scale metabolic networks without sacrificing stoichiometric, thermodynamic and physiological constraints. Biotechnol J 8:1043–1057PubMed
9.
go back to reference Hockin MF, Jones KC, Everse SJ, Mann KG (2002) A model for the stoichiometric regulation of blood coagulation. J Biol Chem 277:18322–18333PubMed Hockin MF, Jones KC, Everse SJ, Mann KG (2002) A model for the stoichiometric regulation of blood coagulation. J Biol Chem 277:18322–18333PubMed
10.
go back to reference Panteleev MA, Ovanesov MV, Kireev DA, Shibeko AM, Sinauridze EI, Ananyeva NM, Butylin AA, Saenko EL, Ataullakhanov FI (2006) Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. Biophys J 90:1489–1500PubMedCentralPubMed Panteleev MA, Ovanesov MV, Kireev DA, Shibeko AM, Sinauridze EI, Ananyeva NM, Butylin AA, Saenko EL, Ataullakhanov FI (2006) Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. Biophys J 90:1489–1500PubMedCentralPubMed
11.
go back to reference Luan D, Zai M, Varner JD (2007) Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies. PLoS Comput Biol 3:e142PubMedCentralPubMed Luan D, Zai M, Varner JD (2007) Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies. PLoS Comput Biol 3:e142PubMedCentralPubMed
12.
go back to reference Anand M, Rajagopal K, Rajagopal KR (2008) A model for the formation, growth, and lysis of clots in quiescent plasma. A comparison between the effects of antithrombin III deficiency and protein C deficiency. J Theor Biol 253:725–738PubMed Anand M, Rajagopal K, Rajagopal KR (2008) A model for the formation, growth, and lysis of clots in quiescent plasma. A comparison between the effects of antithrombin III deficiency and protein C deficiency. J Theor Biol 253:725–738PubMed
13.
go back to reference Chatterjee MS, Denney WS, Jing H, Diamond SL (2010) Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood. PLoS Comput Biol 6:e1000950PubMedCentralPubMed Chatterjee MS, Denney WS, Jing H, Diamond SL (2010) Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood. PLoS Comput Biol 6:e1000950PubMedCentralPubMed
14.
go back to reference Mitrophanov AY, Reifman J (2011) Kinetic modeling sheds light on the mode of action of recombinant factor VIIa on thrombin generation. Thromb Res 128:381–390PubMed Mitrophanov AY, Reifman J (2011) Kinetic modeling sheds light on the mode of action of recombinant factor VIIa on thrombin generation. Thromb Res 128:381–390PubMed
15.
go back to reference Hall CL, Slack SM, Turitto VT (1998) A computational analysis of FXa generation by TF:FVIIa on the surface of rat vascular smooth muscle cells. Ann Biomed Eng 26:28–36PubMed Hall CL, Slack SM, Turitto VT (1998) A computational analysis of FXa generation by TF:FVIIa on the surface of rat vascular smooth muscle cells. Ann Biomed Eng 26:28–36PubMed
16.
go back to reference Kuharsky AL, Fogelson AL (2001) Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition. Biophys J 80:1050–1074PubMedCentralPubMed Kuharsky AL, Fogelson AL (2001) Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition. Biophys J 80:1050–1074PubMedCentralPubMed
17.
go back to reference Ataullakhanov FI, Panteleev MA (2005) Mathematical modeling and computer simulation in blood coagulation. Pathophysiol Haemost Thromb 34:60–70 Ataullakhanov FI, Panteleev MA (2005) Mathematical modeling and computer simulation in blood coagulation. Pathophysiol Haemost Thromb 34:60–70
18.
go back to reference Fogelson AL, Tania N (2005) Coagulation under flow: the influence of flow-mediated transport on the initiation and inhibition of coagulation. Pathophysiol Haemost Thromb 34:91–108PubMed Fogelson AL, Tania N (2005) Coagulation under flow: the influence of flow-mediated transport on the initiation and inhibition of coagulation. Pathophysiol Haemost Thromb 34:91–108PubMed
19.
go back to reference Runyon MK, Kastrup CJ, Johnson-Kerner BL, Ha TG, Ismagilov RF (2008) Effects of shear rate on propagation of blood clotting determined using microfluidics and numerical simulations. J Am Chem Soc 130:3458–3464PubMed Runyon MK, Kastrup CJ, Johnson-Kerner BL, Ha TG, Ismagilov RF (2008) Effects of shear rate on propagation of blood clotting determined using microfluidics and numerical simulations. J Am Chem Soc 130:3458–3464PubMed
20.
go back to reference Xu Z, Christley S, Lioi J, Kim O, Harvey C, Sun W, Rosen ED, Alber M (2012) Multiscale model of fibrin accumulation on the blood clot surface and platelet dynamics. Methods Cell Biol 110:367–388PubMed Xu Z, Christley S, Lioi J, Kim O, Harvey C, Sun W, Rosen ED, Alber M (2012) Multiscale model of fibrin accumulation on the blood clot surface and platelet dynamics. Methods Cell Biol 110:367–388PubMed
21.
go back to reference Neeves KB, Illing DA, Diamond SL (2010) Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys J 98:1344–1352PubMedCentralPubMed Neeves KB, Illing DA, Diamond SL (2010) Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys J 98:1344–1352PubMedCentralPubMed
22.
go back to reference Neeves KB, Onasoga AA, Wufsus AR (2013) The use of microfluidics in hemostasis: clinical diagnostics and biomimetic models of vascular injury. Curr Opin Hematol 20:417–423PubMed Neeves KB, Onasoga AA, Wufsus AR (2013) The use of microfluidics in hemostasis: clinical diagnostics and biomimetic models of vascular injury. Curr Opin Hematol 20:417–423PubMed
23.
go back to reference Butenas S, Orfeo T, Gissel MT, Brummel KE, Mann KG (2004) The significance of circulating factor IXa in blood. J Biol Chem 279:22875–22882PubMed Butenas S, Orfeo T, Gissel MT, Brummel KE, Mann KG (2004) The significance of circulating factor IXa in blood. J Biol Chem 279:22875–22882PubMed
24.
go back to reference Bravo MC, Orfeo T, Mann KG, Everse SJ (2012) Modeling of human factor Va inactivation by activated protein C. BMC Syst Biol 6:45PubMedCentralPubMed Bravo MC, Orfeo T, Mann KG, Everse SJ (2012) Modeling of human factor Va inactivation by activated protein C. BMC Syst Biol 6:45PubMedCentralPubMed
25.
go back to reference Brummel-Ziedins KE, Orfeo T, Callas PW, Gissel M, Mann KG, Bovill EG (2012) The prothrombotic phenotypes in familial protein C deficiency are differentiated by computational modeling of thrombin generation. PLoS ONE 7:e44378PubMedCentralPubMed Brummel-Ziedins KE, Orfeo T, Callas PW, Gissel M, Mann KG, Bovill EG (2012) The prothrombotic phenotypes in familial protein C deficiency are differentiated by computational modeling of thrombin generation. PLoS ONE 7:e44378PubMedCentralPubMed
26.
go back to reference Orfeo T, Butenas S, Brummel-Ziedins KE, Gissel M, Mann KG (2010) Anticoagulation by factor Xa inhibitors. J Thromb Haemost 8:1745–1753PubMedCentralPubMed Orfeo T, Butenas S, Brummel-Ziedins KE, Gissel M, Mann KG (2010) Anticoagulation by factor Xa inhibitors. J Thromb Haemost 8:1745–1753PubMedCentralPubMed
27.
go back to reference Brummel-Ziedins KE, Pouliot RL, Mann KG (2004) Thrombin generation: phenotypic quantitation. J Thromb Haemost 2:281–288PubMed Brummel-Ziedins KE, Pouliot RL, Mann KG (2004) Thrombin generation: phenotypic quantitation. J Thromb Haemost 2:281–288PubMed
28.
go back to reference Crawley JT, Zanardelli S, Chion CK, Lane DA (2007) The central role of thrombin in hemostasis. J Thromb Haemost 5(Suppl 1):95–101PubMed Crawley JT, Zanardelli S, Chion CK, Lane DA (2007) The central role of thrombin in hemostasis. J Thromb Haemost 5(Suppl 1):95–101PubMed
29.
go back to reference Hemker HC, Beguin S (2000) Phenotyping the clotting system. Thromb Haemost 84:747–751PubMed Hemker HC, Beguin S (2000) Phenotyping the clotting system. Thromb Haemost 84:747–751PubMed
30.
go back to reference Brummel-Ziedins K, Vossen CY, Rosendaal FR, Umezaki K, Mann KG (2005) The plasma hemostatic proteome: thrombin generation in healthy individuals. J Thromb Haemost 3:1472–1481PubMedCentralPubMed Brummel-Ziedins K, Vossen CY, Rosendaal FR, Umezaki K, Mann KG (2005) The plasma hemostatic proteome: thrombin generation in healthy individuals. J Thromb Haemost 3:1472–1481PubMedCentralPubMed
31.
go back to reference Brummel-Ziedins KE, Vossen CY, Butenas S, Mann KG, Rosendaal FR (2005) Thrombin generation profiles in deep venous thrombosis. J Thromb Haemost 3:2497–2505PubMedCentralPubMed Brummel-Ziedins KE, Vossen CY, Butenas S, Mann KG, Rosendaal FR (2005) Thrombin generation profiles in deep venous thrombosis. J Thromb Haemost 3:2497–2505PubMedCentralPubMed
32.
go back to reference Brummel-Ziedins K, Undas A, Orfeo T, Gissel M, Butenas S, Zmudka K, Mann KG (2008) Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition. J Thromb Haemost 6:104–110PubMed Brummel-Ziedins K, Undas A, Orfeo T, Gissel M, Butenas S, Zmudka K, Mann KG (2008) Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition. J Thromb Haemost 6:104–110PubMed
33.
go back to reference Brummel-Ziedins KE, Orfeo T, Rosendaal FR, Undas A, Rivard GE, Butenas S, Mann KG (2009) Empirical and theoretical phenotypic discrimination. J Thromb Haemost 7(Suppl 1):181–186PubMedCentralPubMed Brummel-Ziedins KE, Orfeo T, Rosendaal FR, Undas A, Rivard GE, Butenas S, Mann KG (2009) Empirical and theoretical phenotypic discrimination. J Thromb Haemost 7(Suppl 1):181–186PubMedCentralPubMed
34.
go back to reference Brummel-Ziedins KE, Whelihan MF, Gissel M, Mann KG, Rivard GE (2009) Thrombin generation and bleeding in haemophilia A. Haemophilia 15:1118–1125PubMedCentralPubMed Brummel-Ziedins KE, Whelihan MF, Gissel M, Mann KG, Rivard GE (2009) Thrombin generation and bleeding in haemophilia A. Haemophilia 15:1118–1125PubMedCentralPubMed
35.
go back to reference Brummel-Ziedins KE, Orfeo T, Gissel M, Mann KG, Rosendaal FR (2012) Factor Xa generation by computational modeling: an additional discriminator to thrombin generation evaluation. PLoS ONE 7:e29178PubMedCentralPubMed Brummel-Ziedins KE, Orfeo T, Gissel M, Mann KG, Rosendaal FR (2012) Factor Xa generation by computational modeling: an additional discriminator to thrombin generation evaluation. PLoS ONE 7:e29178PubMedCentralPubMed
36.
go back to reference Brummel-Ziedins KE, Lam PH, Gissel M, Gauthier E, Schneider DJ (2013) Depletion of systemic concentrations of coagulation factors in blood from patients with atherosclerotic vascular disease. Coron Artery Dis 24:468–474PubMed Brummel-Ziedins KE, Lam PH, Gissel M, Gauthier E, Schneider DJ (2013) Depletion of systemic concentrations of coagulation factors in blood from patients with atherosclerotic vascular disease. Coron Artery Dis 24:468–474PubMed
37.
go back to reference Baker JV, Brummel-Ziedins K, Neuhaus J, Duprez D, Cummins N, Dalmau D, Dehovitz J, Lehmann C, Sullivan A, Woolley I, Kuller L, Neaton JD, Tracy RP (2013) HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation. J Am Heart Assoc 2:e000264PubMedCentralPubMed Baker JV, Brummel-Ziedins K, Neuhaus J, Duprez D, Cummins N, Dalmau D, Dehovitz J, Lehmann C, Sullivan A, Woolley I, Kuller L, Neaton JD, Tracy RP (2013) HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation. J Am Heart Assoc 2:e000264PubMedCentralPubMed
38.
go back to reference Brummel-Ziedins K (2013) Models for thrombin generation and risk of disease. J Thromb Haemost 11(Suppl 1):212–223PubMed Brummel-Ziedins K (2013) Models for thrombin generation and risk of disease. J Thromb Haemost 11(Suppl 1):212–223PubMed
39.
go back to reference Mann KG, Brummel K, Butenas S (2003) What is all that thrombin for? J Thromb Haemost 1:1504–1514PubMed Mann KG, Brummel K, Butenas S (2003) What is all that thrombin for? J Thromb Haemost 1:1504–1514PubMed
40.
go back to reference Xue J, Wu Q, Westfield LA, Tuley EA, Lu D, Zhang Q, Shim K, Zheng X, Sadler JE (1998) Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci USA 95:7603–7607PubMed Xue J, Wu Q, Westfield LA, Tuley EA, Lu D, Zhang Q, Shim K, Zheng X, Sadler JE (1998) Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci USA 95:7603–7607PubMed
41.
go back to reference Bar-Shavit R, Kahn A, Mudd MS, Wilner GD, Mann KG, Fenton JW 2nd (1984) Localization of a chemotactic domain in human thrombin. Biochemistry 23:397–400PubMed Bar-Shavit R, Kahn A, Mudd MS, Wilner GD, Mann KG, Fenton JW 2nd (1984) Localization of a chemotactic domain in human thrombin. Biochemistry 23:397–400PubMed
42.
go back to reference Bar-Shavit R, Kahn AJ, Mann KG, Wilner GD (1986) Identification of a thrombin sequence with growth factor activity on macrophages. Proc Natl Acad Sci USA 83:976–980PubMed Bar-Shavit R, Kahn AJ, Mann KG, Wilner GD (1986) Identification of a thrombin sequence with growth factor activity on macrophages. Proc Natl Acad Sci USA 83:976–980PubMed
43.
go back to reference Morawitz P (1905) Die chemie der blutgerrinnung. Ergebn Physiol. 4:307 Morawitz P (1905) Die chemie der blutgerrinnung. Ergebn Physiol. 4:307
44.
go back to reference Fuld E, Spiro K (1904) Der einflup einiger gerrinnungshemmender agentien auf das Vogel plasma. Beitr z Chem Phys u Path (Hofmeister’s) 5:171 Fuld E, Spiro K (1904) Der einflup einiger gerrinnungshemmender agentien auf das Vogel plasma. Beitr z Chem Phys u Path (Hofmeister’s) 5:171
45.
go back to reference Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96:11023–11027PubMed Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96:11023–11027PubMed
46.
go back to reference Tracy PB (1988) Regulation of thrombin generation at cell surfaces. Semin Thromb Hemost 14:227–233 Tracy PB (1988) Regulation of thrombin generation at cell surfaces. Semin Thromb Hemost 14:227–233
47.
go back to reference Bouchard BA, Tracy PB (2001) Platelet regulation of thrombin generation in cardiovascular disease. Italian Heart J 2:819–823 Bouchard BA, Tracy PB (2001) Platelet regulation of thrombin generation in cardiovascular disease. Italian Heart J 2:819–823
48.
go back to reference Mosesson MW (1992) The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin Hematol 29:177–188PubMed Mosesson MW (1992) The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin Hematol 29:177–188PubMed
49.
go back to reference Spraggon G, Everse SJ, Doolittle RF (1997) Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 389:455–462PubMed Spraggon G, Everse SJ, Doolittle RF (1997) Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 389:455–462PubMed
50.
go back to reference Hantgan R, McDonagh J, Hermans J (1983) Fibrin assembly. Ann NY Acad Sci 408:344–366PubMed Hantgan R, McDonagh J, Hermans J (1983) Fibrin assembly. Ann NY Acad Sci 408:344–366PubMed
51.
go back to reference Lorand L, Jeong JM, Radek JT, Wilson J (1993) Human plasma factor XIII: subunit interactions and activation of zymogen. Method Enzymol 222:22–35 Lorand L, Jeong JM, Radek JT, Wilson J (1993) Human plasma factor XIII: subunit interactions and activation of zymogen. Method Enzymol 222:22–35
52.
go back to reference Lorand L, Konishi K (1964) Activation of the fibrin-stabilizing factor of plasma by thrombin. Arch Biochem Biophys 105:58PubMed Lorand L, Konishi K (1964) Activation of the fibrin-stabilizing factor of plasma by thrombin. Arch Biochem Biophys 105:58PubMed
53.
go back to reference Yee VC, Pedersen LC, Le TI, Bishop PD, Stenkamp RE, Teller DC (1994) Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc Natl Acad Sci USA 91:7296–7300PubMed Yee VC, Pedersen LC, Le TI, Bishop PD, Stenkamp RE, Teller DC (1994) Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc Natl Acad Sci USA 91:7296–7300PubMed
54.
go back to reference Bajzar L, Manuel R, Nesheim ME (1995) Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 270:14477–14484PubMed Bajzar L, Manuel R, Nesheim ME (1995) Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 270:14477–14484PubMed
55.
go back to reference Bajzar L, Morser J, Nesheim M (1996) TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 271:16603–16608PubMed Bajzar L, Morser J, Nesheim M (1996) TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 271:16603–16608PubMed
56.
go back to reference Mann KG, Jenny RJ, Krishnaswamy S (1988) Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem 57:915–956PubMed Mann KG, Jenny RJ, Krishnaswamy S (1988) Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem 57:915–956PubMed
57.
go back to reference Fay PJ (1988) Subunit structure of thrombin-activated human factor VIIIa. Biochim Biophys Acta 952:181–190PubMed Fay PJ (1988) Subunit structure of thrombin-activated human factor VIIIa. Biochim Biophys Acta 952:181–190PubMed
58.
go back to reference Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG (1987) Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 84:4846–4850PubMed Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG (1987) Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 84:4846–4850PubMed
59.
go back to reference Lollar P, Parker CG (1989) Subunit structure of thrombin-activated porcine factor VIII. Biochemistry 28:666–674PubMed Lollar P, Parker CG (1989) Subunit structure of thrombin-activated porcine factor VIII. Biochemistry 28:666–674PubMed
60.
go back to reference Radcliffe R, Nemerson Y (1975) Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII. J Biol Chem 250:388–395PubMed Radcliffe R, Nemerson Y (1975) Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII. J Biol Chem 250:388–395PubMed
61.
go back to reference Esmon CT (1995) Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 9:946–955PubMed Esmon CT (1995) Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 9:946–955PubMed
63.
64.
go back to reference Kalafatis M, Egan JO (1997) van ‘t Veer C, Cawthern KM, Mann KG. The regulation of clotting factors. Crit Rev Eukaryot Gene Expr 7:241–280PubMed Kalafatis M, Egan JO (1997) van ‘t Veer C, Cawthern KM, Mann KG. The regulation of clotting factors. Crit Rev Eukaryot Gene Expr 7:241–280PubMed
65.
go back to reference Olson ST, Shore JD (1982) Demonstration of a two-step reaction mechanism for inhibition of alpha-thrombin by antithrombin III and identification of the step affected by heparin. J Biol Chem 257:14891–14895PubMed Olson ST, Shore JD (1982) Demonstration of a two-step reaction mechanism for inhibition of alpha-thrombin by antithrombin III and identification of the step affected by heparin. J Biol Chem 257:14891–14895PubMed
66.
go back to reference Parker KA, Tollefsen DM (1985) The protease specificity of heparin cofactor II. Inhibition of thrombin generated during coagulation. J Biol Chem 260:3501–3505PubMed Parker KA, Tollefsen DM (1985) The protease specificity of heparin cofactor II. Inhibition of thrombin generated during coagulation. J Biol Chem 260:3501–3505PubMed
67.
68.
go back to reference Brummel KE, Paradis SG, Butenas S, Mann KG (2002) Thrombin functions during tissue factor-induced blood coagulation. Blood 100:148–152PubMed Brummel KE, Paradis SG, Butenas S, Mann KG (2002) Thrombin functions during tissue factor-induced blood coagulation. Blood 100:148–152PubMed
69.
go back to reference Rand MD, Lock JB, van’t Veer C, Gaffney DP, Mann KG (1996) Blood clotting in minimally altered whole blood. Blood 88:3432–3445PubMed Rand MD, Lock JB, van’t Veer C, Gaffney DP, Mann KG (1996) Blood clotting in minimally altered whole blood. Blood 88:3432–3445PubMed
70.
go back to reference Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, Beguin S, Hemker HC (2002) The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 88:576–582PubMed Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, Beguin S, Hemker HC (2002) The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 88:576–582PubMed
71.
go back to reference Dargaud Y, Beguin S, Lienhart A, Al Dieri R, Trzeciak C, Bordet JC, Hemker HC, Negrier C (2005) Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost 93:475–480PubMed Dargaud Y, Beguin S, Lienhart A, Al Dieri R, Trzeciak C, Bordet JC, Hemker HC, Negrier C (2005) Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost 93:475–480PubMed
72.
go back to reference Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S (2002) The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 32:249–253PubMed Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S (2002) The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 32:249–253PubMed
73.
go back to reference Regnault V, Hemker HC, Wahl D, Lecompte T (2004) Phenotyping the haemostatic system by thrombography—potential for the estimation of thrombotic risk. Thromb Res 114:539–545PubMed Regnault V, Hemker HC, Wahl D, Lecompte T (2004) Phenotyping the haemostatic system by thrombography—potential for the estimation of thrombotic risk. Thromb Res 114:539–545PubMed
74.
go back to reference Allen GA, Hoffman M, Roberts HR, Monroe DM (2006) Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia. Br J Haematol 134:314–319PubMed Allen GA, Hoffman M, Roberts HR, Monroe DM (2006) Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia. Br J Haematol 134:314–319PubMed
75.
go back to reference Allen GA, Persson E, Campbell RA, Ezban M, Hedner U, Wolberg AS (2007) A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia. Arterioscler Thromb Vasc Biol 27:683–689 Allen GA, Persson E, Campbell RA, Ezban M, Hedner U, Wolberg AS (2007) A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia. Arterioscler Thromb Vasc Biol 27:683–689
76.
go back to reference Van’t Veer C, Golden NJ, Mann KG (2000) Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa. Blood 95:1330–1335 Van’t Veer C, Golden NJ, Mann KG (2000) Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa. Blood 95:1330–1335
77.
go back to reference Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG (2002) Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood 99:923–930PubMed Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG (2002) Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood 99:923–930PubMed
78.
go back to reference Gissel M, Whelihan MF, Ferris LA, Mann KG, Rivard GE, Brummel-Ziedins KE (2012) The influence of prophylactic factor VIII in severe haemophilia A. Haemophilia 18:193–199PubMedCentralPubMed Gissel M, Whelihan MF, Ferris LA, Mann KG, Rivard GE, Brummel-Ziedins KE (2012) The influence of prophylactic factor VIII in severe haemophilia A. Haemophilia 18:193–199PubMedCentralPubMed
79.
go back to reference Cawthern KM, van’t Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG (1998) Blood coagulation in hemophilia A and hemophilia C. Blood 91:4581–4592PubMed Cawthern KM, van’t Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG (1998) Blood coagulation in hemophilia A and hemophilia C. Blood 91:4581–4592PubMed
80.
go back to reference Brummel-Ziedins KE, Whelihan MF, Rivard GE, Butenas S (2011) Activated protein C inhibitor for correction of thrombin generation in hemophilia A blood and plasma1. J Thromb Haemost 9:2262–2267PubMed Brummel-Ziedins KE, Whelihan MF, Rivard GE, Butenas S (2011) Activated protein C inhibitor for correction of thrombin generation in hemophilia A blood and plasma1. J Thromb Haemost 9:2262–2267PubMed
81.
go back to reference Poort SR, Michiels JJ, Reitsma PH, Bertina RM (1994) Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder. Thromb Haemost 72:819–824PubMed Poort SR, Michiels JJ, Reitsma PH, Bertina RM (1994) Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder. Thromb Haemost 72:819–824PubMed
82.
go back to reference Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698–3703PubMed Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698–3703PubMed
83.
go back to reference Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Juttler E, Druschky KF, Patscheke H (1998) Prothrombin gene G20210 ≥ A transition is a risk factor for cerebral venous thrombosis. Stroke 29:1765–1769PubMed Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Juttler E, Druschky KF, Patscheke H (1998) Prothrombin gene G20210 ≥ A transition is a risk factor for cerebral venous thrombosis. Stroke 29:1765–1769PubMed
84.
go back to reference Margaglione M, Brancaccio V, Giuliani N, D’Andrea G, Cappucci G, Iannaccone L, Vecchione G, Grandone E, Di Minno G (1998) Increased risk for venous thrombosis in carriers of the prothrombin G ≥ A20210 gene variant. Ann Intern Med 129:89–93PubMed Margaglione M, Brancaccio V, Giuliani N, D’Andrea G, Cappucci G, Iannaccone L, Vecchione G, Grandone E, Di Minno G (1998) Increased risk for venous thrombosis in carriers of the prothrombin G ≥ A20210 gene variant. Ann Intern Med 129:89–93PubMed
85.
go back to reference Quick AJ, Stanley-Brown M, Bancroft FW (1935) A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 190:501 Quick AJ, Stanley-Brown M, Bancroft FW (1935) A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 190:501
86.
go back to reference Owren PA, Aas K (1951) The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest 3:201–208PubMed Owren PA, Aas K (1951) The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest 3:201–208PubMed
87.
go back to reference Langdell RD, Wagner RH, Brinkhous KM (1953) Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. J Lab Clin Med 41:637–647PubMed Langdell RD, Wagner RH, Brinkhous KM (1953) Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. J Lab Clin Med 41:637–647PubMed
88.
go back to reference Nair SC, Dargaud Y, Chitlur M, Srivastava A (2010) Tests of global haemostasis and their applications in bleeding disorders. Haemophilia 16(Suppl 5):85–92PubMed Nair SC, Dargaud Y, Chitlur M, Srivastava A (2010) Tests of global haemostasis and their applications in bleeding disorders. Haemophilia 16(Suppl 5):85–92PubMed
89.
go back to reference Young G, Sorensen B, Dargaud Y, Negrier C, Brummel-Ziedins K, Key NS (2013) Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state-of-art and future perspectives. Blood. 121:1944–1950PubMed Young G, Sorensen B, Dargaud Y, Negrier C, Brummel-Ziedins K, Key NS (2013) Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state-of-art and future perspectives. Blood. 121:1944–1950PubMed
90.
go back to reference van Geffen M, van Heerde WL (2012) Global haemostasis assays, from bench to bedside. Thromb Res 129:681–687PubMed van Geffen M, van Heerde WL (2012) Global haemostasis assays, from bench to bedside. Thromb Res 129:681–687PubMed
91.
go back to reference Hemker HC (2005) Calibrated automated thrombinography (CAT). Thromb Res 115:255PubMed Hemker HC (2005) Calibrated automated thrombinography (CAT). Thromb Res 115:255PubMed
92.
go back to reference Ninivaggi M, Apitz-Castro R, Dargaud Y, de Laat B, Hemker HC, Lindhout T (2012) Whole-blood thrombin generation monitored with a calibrated automated thrombogram-based assay. Clin Chem 58:1252–1259PubMed Ninivaggi M, Apitz-Castro R, Dargaud Y, de Laat B, Hemker HC, Lindhout T (2012) Whole-blood thrombin generation monitored with a calibrated automated thrombogram-based assay. Clin Chem 58:1252–1259PubMed
93.
go back to reference Hartert H (1948) Not Available. Klinische Wochenschrift 26:577–583PubMed Hartert H (1948) Not Available. Klinische Wochenschrift 26:577–583PubMed
94.
go back to reference Lawson JH, Kalafatis M, Stram S, Mann KG (1994) A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem 269:23357–23366PubMed Lawson JH, Kalafatis M, Stram S, Mann KG (1994) A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem 269:23357–23366PubMed
95.
go back to reference Butenas S, van’t Veer C, Mann KG (1999) Normal thrombin generation. Blood 94:2169–2178PubMed Butenas S, van’t Veer C, Mann KG (1999) Normal thrombin generation. Blood 94:2169–2178PubMed
96.
go back to reference Perzborn E, Roehrig S, Straub A, Kubitza D, Mueck W, Laux V (2010) Rivaroxaban: a new oral factor Xa inhibitor. Arterioscler Thromb Vasc Biol 30:376–381PubMed Perzborn E, Roehrig S, Straub A, Kubitza D, Mueck W, Laux V (2010) Rivaroxaban: a new oral factor Xa inhibitor. Arterioscler Thromb Vasc Biol 30:376–381PubMed
97.
go back to reference Foley JH, Orfeo T, Undas A, McLean KC, Bernstein IM, Rivard GE, Mann KG, Everse SJ, Brummel-Ziedins KE (2013) From principle to practice: bridging the gap in patient profiling. PLoS ONE 8:e54728PubMedCentralPubMed Foley JH, Orfeo T, Undas A, McLean KC, Bernstein IM, Rivard GE, Mann KG, Everse SJ, Brummel-Ziedins KE (2013) From principle to practice: bridging the gap in patient profiling. PLoS ONE 8:e54728PubMedCentralPubMed
98.
go back to reference Danforth CM, Orfeo T, Everse SJ, Mann KG, Brummel-Ziedins KE (2012) Defining the boundaries of normal thrombin generation: investigations into hemostasis. PLoS ONE 7:e30385PubMedCentralPubMed Danforth CM, Orfeo T, Everse SJ, Mann KG, Brummel-Ziedins KE (2012) Defining the boundaries of normal thrombin generation: investigations into hemostasis. PLoS ONE 7:e30385PubMedCentralPubMed
99.
go back to reference Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33:4–15PubMed Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33:4–15PubMed
100.
go back to reference Dargaud Y, Francillon S, Negrier C (2009) Intraindividual thrombin generation measurement variability in healthy adults over a 1 year period. Thromb Res 124:237–238PubMed Dargaud Y, Francillon S, Negrier C (2009) Intraindividual thrombin generation measurement variability in healthy adults over a 1 year period. Thromb Res 124:237–238PubMed
101.
go back to reference Haidl H, Cimenti C, Leschnik B, Zach D, Muntean W (2006) Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT). Thromb Haemost 95:772–775PubMed Haidl H, Cimenti C, Leschnik B, Zach D, Muntean W (2006) Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT). Thromb Haemost 95:772–775PubMed
102.
go back to reference McLean KC, Bernstein IM, Brummel-Ziedins KE (2012) Tissue factor-dependent thrombin generation across pregnancy. Am J Obstet Gynecol 207(135):e1–e6PubMed McLean KC, Bernstein IM, Brummel-Ziedins KE (2012) Tissue factor-dependent thrombin generation across pregnancy. Am J Obstet Gynecol 207(135):e1–e6PubMed
103.
go back to reference Dargaud Y, Hierso S, Rugeri L, Battie C, Gaucherand P, Negrier C, Trzeciak MC (2010) Endogenous thrombin potential, prothrombin fragment 1 + 2 and d-dimers during pregnancy. Thromb Haemost 103:469–471PubMed Dargaud Y, Hierso S, Rugeri L, Battie C, Gaucherand P, Negrier C, Trzeciak MC (2010) Endogenous thrombin potential, prothrombin fragment 1 + 2 and d-dimers during pregnancy. Thromb Haemost 103:469–471PubMed
104.
go back to reference Eichinger S, Weltermann A, Philipp K, Hafner E, Kaider A, Kittl EM, Brenner B, Mannhalter C, Lechner K, Kyrle PA (1999) Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 82:1232–1236PubMed Eichinger S, Weltermann A, Philipp K, Hafner E, Kaider A, Kittl EM, Brenner B, Mannhalter C, Lechner K, Kyrle PA (1999) Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 82:1232–1236PubMed
105.
go back to reference Kjellberg U, Andersson NE, Rosen S, Tengborn L, Hellgren M (1999) APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 81:527–531PubMed Kjellberg U, Andersson NE, Rosen S, Tengborn L, Hellgren M (1999) APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 81:527–531PubMed
106.
go back to reference Curvers J, Thomassen MC, Rimmer J, Hamulyak K, van der Meer J, Tans G, Preston FE, Rosing J (2002) Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test. Thromb Haemost 88:5–11PubMed Curvers J, Thomassen MC, Rimmer J, Hamulyak K, van der Meer J, Tans G, Preston FE, Rosing J (2002) Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test. Thromb Haemost 88:5–11PubMed
107.
go back to reference Rosenkranz A, Hiden M, Leschnik B, Weiss EC, Schlembach D, Lang U, Gallistl S, Muntean W (2008) Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost 99:331–337PubMed Rosenkranz A, Hiden M, Leschnik B, Weiss EC, Schlembach D, Lang U, Gallistl S, Muntean W (2008) Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost 99:331–337PubMed
108.
go back to reference Bartsch P, Welsch B, Albert M, Friedmann B, Levi M, Kruithof EK (1995) Balanced activation of coagulation and fibrinolysis after a 2-h triathlon. Med Sci Sports Exerc 27:1465–1470PubMed Bartsch P, Welsch B, Albert M, Friedmann B, Levi M, Kruithof EK (1995) Balanced activation of coagulation and fibrinolysis after a 2-h triathlon. Med Sci Sports Exerc 27:1465–1470PubMed
109.
go back to reference Weiss C, Seitel G, Bartsch P (1998) Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects. Med Sci Sports Exerc 30:246–251PubMed Weiss C, Seitel G, Bartsch P (1998) Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects. Med Sci Sports Exerc 30:246–251PubMed
110.
go back to reference Weiss C, Velich T, Niebauer J, Hauer K, Kalberer B, Kubler W, Bartsch P (1998) Activation of coagulation and fibrinolysis after rehabilitative exercise in patients with coronary artery disease. Am J Cardiol 81:672–677PubMed Weiss C, Velich T, Niebauer J, Hauer K, Kalberer B, Kubler W, Bartsch P (1998) Activation of coagulation and fibrinolysis after rehabilitative exercise in patients with coronary artery disease. Am J Cardiol 81:672–677PubMed
111.
go back to reference Cimenti C, Schlagenhauf A, Leschnik B, Schretter M, Tschakert G, Groschl W, Seibert FJ, Hofmann P, Muntean WE (2013) Low endogenous thrombin potential in trained subjects. Thromb Res 131:e281–e285PubMed Cimenti C, Schlagenhauf A, Leschnik B, Schretter M, Tschakert G, Groschl W, Seibert FJ, Hofmann P, Muntean WE (2013) Low endogenous thrombin potential in trained subjects. Thromb Res 131:e281–e285PubMed
112.
go back to reference Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD (1995) Hypercoagulability in centenarians: the paradox of successful aging. Blood 85:3144–3149PubMed Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD (1995) Hypercoagulability in centenarians: the paradox of successful aging. Blood 85:3144–3149PubMed
113.
go back to reference Sagripanti A, Carpi A (1998) Natural anticoagulants, aging, and thromboembolism. Exp Gerontol 33:891–896PubMed Sagripanti A, Carpi A (1998) Natural anticoagulants, aging, and thromboembolism. Exp Gerontol 33:891–896PubMed
114.
go back to reference Holmes VA, Wallace JM (2005) Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 33:428–432PubMed Holmes VA, Wallace JM (2005) Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 33:428–432PubMed
115.
go back to reference Bremme KA (2003) Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16:153–168PubMed Bremme KA (2003) Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16:153–168PubMed
116.
go back to reference O’Donnell J, Mumford AD, Manning RA, Laffan MA (2001) Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism. Br J Haematol 115:687–691PubMed O’Donnell J, Mumford AD, Manning RA, Laffan MA (2001) Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism. Br J Haematol 115:687–691PubMed
117.
go back to reference Tripodi A, Primignani M, Chantarangkul V, Dell’Era A, Clerici M, de Franchis R, Colombo M, Mannucci PM (2009) An imbalance of pro- versus anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 137:2105–2111PubMed Tripodi A, Primignani M, Chantarangkul V, Dell’Era A, Clerici M, de Franchis R, Colombo M, Mannucci PM (2009) An imbalance of pro- versus anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 137:2105–2111PubMed
118.
go back to reference Allen GA, Wolberg AS, Oliver JA, Hoffman M, Roberts HR, Monroe DM (2004) Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost 2:402–413PubMed Allen GA, Wolberg AS, Oliver JA, Hoffman M, Roberts HR, Monroe DM (2004) Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost 2:402–413PubMed
119.
go back to reference Xi M, Beguin S, Hemker HC (1989) The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemost 62:788–791PubMed Xi M, Beguin S, Hemker HC (1989) The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemost 62:788–791PubMed
120.
go back to reference Brummel-Ziedins KE, Branda RF, Butenas S, Mann KG (2009) Discordant fibrin formation in hemophilia. J Thromb Haemost 7:825–832PubMedCentralPubMed Brummel-Ziedins KE, Branda RF, Butenas S, Mann KG (2009) Discordant fibrin formation in hemophilia. J Thromb Haemost 7:825–832PubMedCentralPubMed
121.
go back to reference Brummel Ziedins K, Rivard GE, Pouliot RL, Butenas S, Gissel M, Parhami-Seren B, Mann KG (2004) Factor VIIa replacement therapy in factor VII deficiency. J Thromb Haemost 2:1735–1744PubMed Brummel Ziedins K, Rivard GE, Pouliot RL, Butenas S, Gissel M, Parhami-Seren B, Mann KG (2004) Factor VIIa replacement therapy in factor VII deficiency. J Thromb Haemost 2:1735–1744PubMed
122.
go back to reference Brummel-Ziedins K, Callas PW, Orfeo T, Gissel M, Hockin MF, Mann KG, Bovill EG (2009) Evaluating thrombin generation in a family with protein C deficiency. J Thromb Haemost 7:162–163 Brummel-Ziedins K, Callas PW, Orfeo T, Gissel M, Hockin MF, Mann KG, Bovill EG (2009) Evaluating thrombin generation in a family with protein C deficiency. J Thromb Haemost 7:162–163
123.
go back to reference Foley JH, Ferris L, Brummel-Ziedins KE (2012) Characteristics of fibrin formation and clot stability in individuals with congenital type IIb protein C deficiency. Thromb Res 129:e142–e146PubMedCentralPubMed Foley JH, Ferris L, Brummel-Ziedins KE (2012) Characteristics of fibrin formation and clot stability in individuals with congenital type IIb protein C deficiency. Thromb Res 129:e142–e146PubMedCentralPubMed
124.
go back to reference Undas A, Jankowski M, Kaczmarek P, Sladek K, Brummel-Ziedins K (2011) Thrombin generation in chronic obstructive pulmonary disease: dependence on plasma factor composition. Thromb Res 128:e24–e28PubMedCentralPubMed Undas A, Jankowski M, Kaczmarek P, Sladek K, Brummel-Ziedins K (2011) Thrombin generation in chronic obstructive pulmonary disease: dependence on plasma factor composition. Thromb Res 128:e24–e28PubMedCentralPubMed
125.
go back to reference Gissel M, Undas A, Slowik A, Mann KG, Brummel-Ziedins KE (2010) Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events. Thromb Res 126:262–269PubMedCentralPubMed Gissel M, Undas A, Slowik A, Mann KG, Brummel-Ziedins KE (2010) Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events. Thromb Res 126:262–269PubMedCentralPubMed
126.
go back to reference Undas A, Gissel M, Kwasny-Krochin B, Gluszko P, Mann KG, Brummel-Ziedins KE (2010) Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition. Thromb Haemost 104:224–230PubMedCentralPubMed Undas A, Gissel M, Kwasny-Krochin B, Gluszko P, Mann KG, Brummel-Ziedins KE (2010) Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition. Thromb Haemost 104:224–230PubMedCentralPubMed
127.
go back to reference Brummel-Ziedins KE, Gissel M, Francis C, Queenan J, Mann KG (2009) The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization. Thromb Res 124:505–507PubMedCentralPubMed Brummel-Ziedins KE, Gissel M, Francis C, Queenan J, Mann KG (2009) The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization. Thromb Res 124:505–507PubMedCentralPubMed
128.
go back to reference Danforth CM, Orfeo T, Mann KG, Brummel-Ziedins KE, Everse SJ (2009) The impact of uncertainty in a blood coagulation model. Math Med Biol 26:323–336PubMed Danforth CM, Orfeo T, Mann KG, Brummel-Ziedins KE, Everse SJ (2009) The impact of uncertainty in a blood coagulation model. Math Med Biol 26:323–336PubMed
129.
go back to reference Aleman MM, Walton BL, Byrnes JR, Wang JG, Heisler MJ, Machlus KR, Cooley BC, Wolberg AS (2013) Elevated prothrombin promotes venous, but not arterial, thrombosis in mice. Arterioscler Thromb Vasc Biol 33:1829–1836PubMed Aleman MM, Walton BL, Byrnes JR, Wang JG, Heisler MJ, Machlus KR, Cooley BC, Wolberg AS (2013) Elevated prothrombin promotes venous, but not arterial, thrombosis in mice. Arterioscler Thromb Vasc Biol 33:1829–1836PubMed
Metadata
Title
Modeling thrombin generation: plasma composition based approach
Authors
Kathleen E. Brummel-Ziedins
Stephen J. Everse
Kenneth G. Mann
Thomas Orfeo
Publication date
01-01-2014
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2014
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-013-1006-9

Other articles of this Issue 1/2014

Journal of Thrombosis and Thrombolysis 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine